SCHEMBL11913440

SCHEMBL11913440

Cc1c[nH]c2nc(-c3ccc(Cl)c(N(C)C)c3F)nc(C)c12

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ TGFBR1 P36897 1/20 0.30
▸ TGFBR2 P37173 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11903110 0.83 ROCK2 (0.31) —
SCHEMBL11913424 0.82 DYRK1A (0.35) TGFBR1TGFBR2
SCHEMBL11913445 0.81 ADORA2A (0.31) —
SCHEMBL11913446 0.76 SGK1 (0.30) —
SCHEMBL11913448 0.73 CYP1A2 (0.38) TGFBR1TGFBR2
SCHEMBL11918051 0.72 DYRK1A (0.38) TGFBR1TGFBR2
SCHEMBL10087232 0.69 — —
SCHEMBL11918013 0.68 MEP1B (0.33) —
SCHEMBL11903262 0.68 LIMK1 (0.31) —
SCHEMBL1654718 0.68 TAS1R3 (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120202690-A1 HERBICIDAL COMPOUNDS SYNGENTA LIMITED (US) 2012-08-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120202690-A1 HERBICIDAL COMPOUNDS DDT, HAO2, HAAO TGFBR1 2845/4885TGFBR2 2769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback